Telstar has recently extended their manufacturing area to face a progressive demand for growth of pharmaceutical process equipment integrating sterilization technology. The company has responded accordingly in line with the market increase for Telstar branded sterilization systems, which has grown 40% in the last two years, particularly for integrated equipment developed using in-house technologies.

More than 50 years of experience have led Telstar to acquire considerable knowledge and know-how in the development of pharmaceutical plants, laboratories, and high-technology integrated equipment. In the sterilization technology field, well-known international companies have put all their trust in Telstar as a technological partner to carry out complete and integrated process systems and complete turnkey facilities addressed to pharmaceutical industry and medical device sector. The range of sterilization equipment designed by the company comprises of solutions using Ethilene Oxide Sterilization, depyrogenation and dry heat ovens, steam autoclaves and counter pressure autoclaves.

Telstar uses its own resources to develop projects and all the associated process equipment through its team of professionals who have full control over the design and manufacturing process. For the manufacturing process, the company has its own welding shop for fabrication of stainless steel vessels. Through an innovative sterilization & freeze-drying processes R&D laboratory, Telstar offers pharmaceutical companies a qualified and complete consultancy service for the development, qualification and validation of process cycles, simplifying the assessment of a product’s behavior before the freeze drying or sterilization process, as well as adapting and optimizing the process before its industrial implementation.

Telstar, part of the azbil Group, leads the Life Science Engineering business division to develop high-technology solutions of engineering, construction, process equipment and services for the life sciences market.